These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10380970)

  • 1. Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions.
    Murer MG; Ferrario J; Delfino M; Dziewczapolski G; Gershanik OS; Raisman-Vozari R
    Neuroreport; 1999 May; 10(7):1501-5. PubMed ID: 10380970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats.
    De Deurwaèrdere P; Chesselet MF
    J Neurosci; 2000 Jul; 20(13):5170-8. PubMed ID: 10864974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.
    Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A
    Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
    Périer C; Marin C; Jimenez A; Bonastre M; Tolosa E; Hirsch EC
    J Neurochem; 2003 Sep; 86(6):1328-37. PubMed ID: 12950442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease.
    Marin C; Bonastre M; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA
    Exp Neurol; 2013 Dec; 250():304-12. PubMed ID: 24140562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat.
    Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
    Eur J Neurosci; 2000 Dec; 12(12):4338-44. PubMed ID: 11122344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
    Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats.
    Ruskin DN; Marshall JF
    Brain Res; 1995 Dec; 703(1-2):156-64. PubMed ID: 8719628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus.
    Honey CR; Shen H
    Neurosci Lett; 1998 Jun; 249(2-3):151-4. PubMed ID: 9682839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.
    Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
    Synapse; 2001 May; 40(2):145-53. PubMed ID: 11252026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus.
    Soghomonian JJ
    Eur J Neurosci; 2006 May; 23(9):2395-403. PubMed ID: 16706847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of rotational behavior induced by repeated administration of SKF38393 in rats with unilateral nigrostriatal 6-OHDA lesions.
    Matsuda H; Hiyama Y; Terasawa K; Watanabe H; Matsumoto K
    Pharmacol Biochem Behav; 1992 Jun; 42(2):213-8. PubMed ID: 1385877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Globus pallidus lesions depress the excitatory responses to apomorphine but not amphetamine in the subthalamic nucleus of the behaving rat with a 6-OHDA nigra lesion.
    Olds ME; Jacques DB; Kopyov O
    Brain Res; 1998 Nov; 812(1-2):50-64. PubMed ID: 9813239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
    He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
    Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra pars reticulata single unit activity in normal and 60HDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions.
    Murer MG; Riquelme LA; Tseng KY; Pazo JH
    Synapse; 1997 Dec; 27(4):278-93. PubMed ID: 9372551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.